BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹1,136 Cr | ₹948 Cr | ₹844 Cr | ₹700 Cr | ₹717 Cr |
What is the latest Contingent Liabilities ratio of BIOCON ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹1,136 Cr |
Mar2023 | ₹948 Cr |
Mar2022 | ₹844 Cr |
Mar2021 | ₹700 Cr |
Mar2020 | ₹717 Cr |
How is Contingent Liabilities of BIOCON Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,136 Cr | 19.81 | |
Mar2023 | ₹948 Cr | 12.25 | |
Mar2022 | ₹844 Cr | 20.63 | |
Mar2021 | ₹700 Cr | -2.37 | |
Mar2020 | ₹717 Cr | - |
Compare Contingent Liabilities of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹41,594.8 Cr | -1.1% | -1.8% | 40.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | -1.1% |
-1.8% |
40.4% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses